Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions

Z Chen, F Han, Y Du, H Shi, W Zhou - Signal transduction and targeted …, 2023 - nature.com
Having a hypoxic microenvironment is a common and salient feature of most solid tumors.
Hypoxia has a profound effect on the biological behavior and malignant phenotype of …

Hypoxia signaling in human health and diseases: implications and prospects for therapeutics

Z Luo, M Tian, G Yang, Q Tan, Y Chen, G Li… - Signal transduction and …, 2022 - nature.com
Molecular oxygen (O2) is essential for most biological reactions in mammalian cells. When
the intracellular oxygen content decreases, it is called hypoxia. The process of hypoxia is …

Targeting MAPK signaling in cancer: mechanisms of drug resistance and sensitivity

S Lee, J Rauch, W Kolch - International journal of molecular sciences, 2020 - mdpi.com
Mitogen-activated protein kinase (MAPK) pathways represent ubiquitous signal transduction
pathways that regulate all aspects of life and are frequently altered in disease. Here, we …

FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer

M Han, F Li, Y Zhang, P Dai, J He, Y Li, Y Zhu, J Zheng… - Cancer Cell, 2022 - cell.com
Prostate cancer adeno-to-neuroendocrine lineage transition has emerged as a mechanism
of targeted therapeutic resistance. Identifying the direct molecular drivers and developing …

Targeting signaling pathways in prostate cancer: mechanisms and clinical trials

Y He, W Xu, YT Xiao, H Huang, D Gu… - Signal transduction and …, 2022 - nature.com
Prostate cancer (PCa) affects millions of men globally. Due to advances in understanding
genomic landscapes and biological functions, the treatment of PCa continues to improve …

Clinical and biological features of neuroendocrine prostate cancer

Y Yamada, H Beltran - Current oncology reports, 2021 - Springer
Abstract Purpose of Review Neuroendocrine prostate cancer (NEPC) is an aggressive
histologic subtype of prostate cancer that most commonly arises in later stages of prostate …

[HTML][HTML] Epigenomic state transitions characterize tumor progression in mouse lung adenocarcinoma

LM LaFave, VK Kartha, S Ma, K Meli, I Del Priore… - Cancer cell, 2020 - cell.com
Regulatory networks that maintain functional, differentiated cell states are often dysregulated
in tumor development. Here, we use single-cell epigenomics to profile chromatin state …

The role of lineage plasticity in prostate cancer therapy resistance

H Beltran, A Hruszkewycz, HI Scher, J Hildesheim… - Clinical cancer …, 2019 - AACR
Lineage plasticity has emerged as an important mechanism of treatment resistance in
prostate cancer. Treatment-refractory prostate cancers are increasingly associated with loss …

Molecular events in neuroendocrine prostate cancer development

Y Wang, Y Wang, X Ci, SYC Choi, F Crea, D Lin… - Nature Reviews …, 2021 - nature.com
Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. NEPC arises
de novo only rarely; the disease predominantly develops from adenocarcinoma in response …

Aggressive variants of prostate cancer: underlying mechanisms of neuroendocrine transdifferentiation

L Merkens, V Sailer, D Lessel, E Janzen… - Journal of Experimental …, 2022 - Springer
Prostate cancer is a hormone-driven disease and its tumor cell growth highly relies on
increased androgen receptor (AR) signaling. Therefore, targeted therapy directed against …